Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders


Sector: Healthcare | Sub-Sector: Diagnostics & Research
Alternate Symbol(s):  SEOVF

Sernova Corp is a clinical stage biotechnology company. It is engaged in the research and development of a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases.
Price: $0.27 Volume: 186,500
Change: +$0.02 % Change: +8.00%
Day High/Low: 0.28/0.255 52 Week High/Low: 0.33/0.125
Last Traded: September 03, 2015 11:40 Transaction Volume: 500
Open: 0.26 Previous Close: 0.25
Bid: 0.27 Ask: 0.28
Bid Size: 14500 Ask Size: 26000
Market Cap: 38.2m Shares Out: 141.5m
PE Ratio: N/A Dividend Yield: N/A


Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   May 16, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Progress update on Sernova and N.A. Nickel

Sernova’s product focus is on treating insulin-dependent diabetes. NAN is focused on greenfields nickel exploration.

Richard (Rick) Mills   July 17, 2012
0 stars

Latest Bullboard Posts

  • RE:Dr. S

    0 stars

    I have posted this in the past,  however it may be timely for new shareholders. from my research I believe SVA are ahead of the...

    2.5 stars

  • RE:Dr. S

    2.5 stars

    I hope he'll continue with Sernova's clinical trial we think it works better. He has a right to continue any research he thinks will work...

    2 stars

  • Dr. S

    5 stars

    I sure hope the Sernova team is not putting to many resourses towards their dealings with Dr. S. He seems to be batting for the other...

    2 stars

  • New here.

    2 stars

    I'm new to this stock so really don't have much to comment about. Have read the last couple of month's posts and visited Sernova's...

    1 star

  • Re: Share Price

    0 stars

    Summer Doldrums I guess. Hopefully a run upwards in the fall. At least it's not trading large volume on a downturn.

    1 star